Delivery Order SPE2DB24D2100-SPE2DB24FBDHN
Award Date
9/3/24
Potential Completion Date
9/4/24
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PEDVAXHIB vaccine vials. The contract has a ceiling value of $7,583.60 and a period of performance through June 16, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical division, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,817.10 firm-fixed-price delivery order is for the supply of PEDVAXHIB vaccine vials. The contract has an ultimate completion date of December 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of PEDVAXHIB vaccine vials. The $7,976.88 firm fixed-price contract has an ultimate completion date of August 9, 2024. This delivery order is part of a larger indefinite delivery contract with DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables the government to efficiently...
This is a $1,055.28 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the PEDVAXHIB vaccine in 0.5 mL vials, with a completion date of September 25, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities to support military...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the PEDVAXHIB vaccine in 0.5 milliliter vials. The $2,405.65 contract has a completion date of June 23, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, that enables the company to supply a wide range of pharmaceutical products and...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of PEDVAXHIB vaccine vials. The $2,716.80 firm-fixed-price contract has a completion date of May 3, 2024 and is not set aside for any specific business category. Amerisourcebergen holds a larger indefinite delivery contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,085.49 firm fixed-price delivery order is for the supply of PEDVAXHIB vaccine vials (0.5 mL). The contract has an ultimate completion date of June 24, 2025 and is not set aside for any specific business designation. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $2,377.16 contract is for the delivery of PEDVAXHIB vaccine vials to support military treatment programs and facilities. This award is issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order worth $4,303.68 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide PEDVAXHIB vaccine vials. This delivery order is part of a larger indefinite delivery contract (IDC) worth up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to supply a comprehensive range of pharmaceutical products and medical supplies to military treatment programs and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,482.08 firm fixed-price delivery order is for the supply of the PEDVAXHIB vaccine, a 0.5 ML vial. The contract has a completion date of November 21, 2024 and was awarded on November 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division,...